Overview
- Reviews relevant aspects of the biology, diagnosis and management, with particular emphasis on the emerging data available for this disease
Part of the book series: Cancer Treatment and Research (CTAR, volume 131)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (14 chapters)
-
Front Matter
-
Back Matter
Keywords
About this book
Over recent years, there has been a dramatic increase in knowledge of the biology of the lymphomas which has been accompanied by the emergence of new treatments that offer both improvements in efficacy and reduction in toxicity. Molecular profiling of tumor tissue and other new advances have led to a better understanding of the genetic basis of lymphoma, identification of new therapeutic targets, and potentially valuable prognostic information. Monoclonal antibody therapies, radioimmunoconjugates and other new agents such as proteosome inhibitors are providing important new treatment options for patients.
In this volume, an internationally recognized group of experts provides a comprehensive overview of the biology, pathology, standard treatments, and novel approaches in management of patients across the complex landscape of lymphoma subtypes. Researchers and practitioners alike will welcome this useful summary of the state of the art in this field.
Editors and Affiliations
Bibliographic Information
Book Title: Hodgkin's and Non-Hodgkin's Lymphoma
Editors: John P. Leonard, Morton Coleman
Series Title: Cancer Treatment and Research
DOI: https://doi.org/10.1007/978-0-387-29346-2
Publisher: Springer New York, NY
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer-Verlag US 2006
Hardcover ISBN: 978-0-387-29345-5Published: 10 February 2006
Softcover ISBN: 978-1-4419-3987-6Published: 21 September 2014
eBook ISBN: 978-0-387-29346-2Published: 05 March 2008
Series ISSN: 0927-3042
Series E-ISSN: 2509-8497
Edition Number: 1
Number of Pages: XII, 476
Topics: Oncology, Hematology, Pathology, Interventional Radiology